Clinical Trial Update: Post-Marketing Surveillance of Humira in Korean Pediatric Crohn's Disease (CD) Patients Under the "New-Drug Re-examination"

View source ↗

Summary

Post-marketing surveillance study of Humira in Korean pediatric Crohn's disease patients completed; results posted in 2018.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Humira (adalimumab)

Snippet

Sponsor: AbbVie | Conditions: Pediatric Crohn's Disease | Status: COMPLETED | Results posted: 2018-12-19